These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis. Chang K; Svabek C; Vazquez-Guillamet C; Sato B; Rasche D; Wilson S; Robbins P; Ulbrandt N; Suzich J; Green J; Patera AC; Blair W; Krishnan S; Hotchkiss R Crit Care; 2014 Jan; 18(1):R3. PubMed ID: 24387680 [TBL] [Abstract][Full Text] [Related]
3. Blockade of the negative co-stimulatory molecules PD-1 and CTLA-4 improves survival in primary and secondary fungal sepsis. Chang KC; Burnham CA; Compton SM; Rasche DP; Mazuski RJ; McDonough JS; Unsinger J; Korman AJ; Green JM; Hotchkiss RS Crit Care; 2013 May; 17(3):R85. PubMed ID: 23663657 [TBL] [Abstract][Full Text] [Related]
4. Farnesyltransferase inhibitor FTI-277 inhibits PD-L1 expression on septic spleen lymphocytes and promotes spleen lymphocyte activation. Li W; Tu J; Liu X; Yang W Clin Exp Immunol; 2017 Oct; 190(1):8-18. PubMed ID: 28556912 [TBL] [Abstract][Full Text] [Related]
5. Candida auris Bloodstream Infection Induces Upregulation of the PD-1/PD-L1 Immune Checkpoint Pathway in an Immunocompetent Mouse Model. Wurster S; Albert ND; Kontoyiannis DP mSphere; 2022 Apr; 7(2):e0081721. PubMed ID: 35224979 [TBL] [Abstract][Full Text] [Related]
6. [Effect of dendritic cells on immune function regulated by programmed cell death-1/programmed cell death-ligand 1 in sepsis]. Wang Z; Xie Z; Zhao Y; Bu T; Yu A; Wang S Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Sep; 33(9):1032-1039. PubMed ID: 34839857 [TBL] [Abstract][Full Text] [Related]
7. Lymphocyte subset expression and serum concentrations of PD-1/PD-L1 in sepsis - pilot study. Wilson JK; Zhao Y; Singer M; Spencer J; Shankar-Hari M Crit Care; 2018 Apr; 22(1):95. PubMed ID: 29661225 [TBL] [Abstract][Full Text] [Related]
8. Early Activation of Myeloid-Derived Suppressor Cells Participate in Sepsis-Induced Immune Suppression via PD-L1/PD-1 Axis. Ruan WS; Feng MX; Xu J; Xu YG; Song CY; Lin LY; Li L; Lu YQ Front Immunol; 2020; 11():1299. PubMed ID: 32719675 [No Abstract] [Full Text] [Related]
9. [Effects and molecular mechanism of histone methyltransferase enhancer of zeste homolog 2 on regulating sepsis-induced T cell dysfunction]. Li Z; Zhao D; Zhou X; Tang L Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Apr; 34(4):357-361. PubMed ID: 35692198 [TBL] [Abstract][Full Text] [Related]
10. PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction. Zhang Y; Zhou Y; Lou J; Li J; Bo L; Zhu K; Wan X; Deng X; Cai Z Crit Care; 2010; 14(6):R220. PubMed ID: 21118528 [TBL] [Abstract][Full Text] [Related]
11. The Role of Programmed Cell Death 1/Programmed Death Ligand 1 (PD-1/PD-L1) Axis in Sepsis-Induced Apoptosis. Coman O; Grigorescu BL; Huțanu A; Bacârea A; Văsieșiu AM; Fodor RȘ; Stoica F; Azamfirei L Medicina (Kaunas); 2024 Jul; 60(7):. PubMed ID: 39064603 [No Abstract] [Full Text] [Related]
12. Indirect Impact of PD-1/PD-L1 Blockade on a Murine Model of NK Cell Exhaustion. Alvarez M; Simonetta F; Baker J; Morrison AR; Wenokur AS; Pierini A; Berraondo P; Negrin RS Front Immunol; 2020; 11():7. PubMed ID: 32117218 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic Effect of an Anti-Human Programmed Death-Ligand 1 (PD-L1) Nanobody on Polymicrobial Sepsis in Humanized Mice. Zhao ZZ; Wang XL; Xie J; Chen LP; Li Q; Wang XX; Wang JF; Deng XM Med Sci Monit; 2021 Jan; 27():e926820. PubMed ID: 33421049 [TBL] [Abstract][Full Text] [Related]
14. Glutamine Administration in Early or Late Septic Phase Downregulates Lymphocyte PD-1/PD-L1 Expression and the Inflammatory Response in Mice With Polymicrobial Sepsis. Hu YM; Hsiung YC; Pai MH; Yeh SL JPEN J Parenter Enteral Nutr; 2018 Mar; 42(3):538-549. PubMed ID: 28633555 [TBL] [Abstract][Full Text] [Related]
15. MiR-142 inhibits cecal ligation and puncture (CLP)-induced inflammation via inhibiting PD-L1 expression in macrophages and improves survival in septic mice. Zhen J; Chen W Biomed Pharmacother; 2018 Jan; 97():1479-1485. PubMed ID: 29793310 [TBL] [Abstract][Full Text] [Related]
16. PD-L1 Blockade Improves Survival in Sepsis by Reversing Monocyte Dysfunction and Immune Disorder. Yang L; Gao Q; Li Q; Guo S Inflammation; 2024 Feb; 47(1):114-128. PubMed ID: 37776443 [TBL] [Abstract][Full Text] [Related]
17. Frontline Science: Defects in immune function in patients with sepsis are associated with PD-1 or PD-L1 expression and can be restored by antibodies targeting PD-1 or PD-L1. Patera AC; Drewry AM; Chang K; Beiter ER; Osborne D; Hotchkiss RS J Leukoc Biol; 2016 Dec; 100(6):1239-1254. PubMed ID: 27671246 [TBL] [Abstract][Full Text] [Related]
18. [Research advances of myeloid-derived suppressor cells mediated by programmed death-1/programmed death-ligand 1 pathway in sepsis-induced immunosuppression]. Xu Y; Zang X; Chen W Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2024 Mar; 36(3):332-336. PubMed ID: 38538366 [TBL] [Abstract][Full Text] [Related]
19. Killing efficiency affected by mutually modulated PD-1 and PD-L1 expression via NKT-hepatoma cell interactions. Liu L; Yang M; Xu Q; Zhou M; Cheng Y; Xu H; Qin Y; Liu B Immunotherapy; 2021 Feb; 13(2):113-123. PubMed ID: 33076728 [No Abstract] [Full Text] [Related]
20. Interleukin-7 and anti-programmed cell death 1 antibody have differing effects to reverse sepsis-induced immunosuppression. Shindo Y; Unsinger J; Burnham CA; Green JM; Hotchkiss RS Shock; 2015 Apr; 43(4):334-43. PubMed ID: 25565644 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]